Commercial Information Circulars
24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : EIC 631/2/5/1
EIC 631/22/1
10 February 2022
Dear Sirs,
Commercial Information Circular No. 120/2022
The Mainland of China : Notice Concerning the Launch of Approval Documents Related to Imports of Drugs and Medical Devices from Hong Kong and Macao in Urgent Clinical Use in the Guangdong-Hong Kong-Macao Greater Bay Area
Three government departments including the Guangdong Provincial Medical Products Administration issued on 26 January 2022 the "Notice Concerning the Launch of Approval Documents Related to Imports of Drugs and Medical Devices from Hong Kong and Macao in Urgent Clinical Use in the Guangdong-Hong Kong-Macao Greater Bay Area". Starting from 1 March 2022, the approval documents related to imports of drugs and medical devices from Hong Kong and Macao in urgent clinical use in the Guangdong-Hong Kong-Macao Greater Bay Area will be officially launched. The original approval documents can be normally used within the validity period without replacement, and will automatically become invalid after the expiration of the validity period. Please refer to the Appendix (pdf format) for the notice (available in Chinese only).
ENQUIRIES
2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Calvin CHOY)
for Director-General of Trade and Industry
Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.